<p>Growth was monitored by MTT assays. Cells were treated with gefitinib 5 µM and DIM-C 3 µM and compared to each drug alone. Red: gefitinib; Yellow: DIM-C; Blue: gefitinib+DIM-C.</p
<p><b>A</b>. (a) Cell viability analysis according to treatment with simvastatin (10 μM) and <i>NF-κ...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
<p><i>(A and B)</i> MTT cell viability assays to evaluate the potential of metformin (0–20 mM) or lo...
<p>The concentration-response response for each drug was used to determine the concentration that in...
<p>Three relatively resistant cell lines to gefitinib (UM-UC3, UM-UC13, and KU-7) and one sensitive ...
<p>Cells were treated with three different sequences of gefitinib and docetaxel (D→G; G→D; D+G). The...
<p>The effects of (A) gefitinib and (B) erlotinib (1–10 μM) on cell proliferation of A549 cells were...
<p>(A) MTS assay comparing the survival curves of control JLO-1 to 2 µM gefitinib-treated JLO-1 when...
<p>The cells were treated with YC alone or in combination with gefitinib or rapamycin for 48 h. The ...
<p>Bladder tumor growth of combination treatment arm compared to control arm (P<0.02). Ten mice per ...
<p>(A) PC-9/wt, PC-9/gefB4 and PC-9/gefE3 cells were treated with gefitinib (nM) at various concentr...
<p>(<b>A</b>) SKBR3 and MDA-MB-468 cells were treated with DIM (15 µM) and Herceptin (0.75 µg/ml), e...
<p>(a) Confocal microscopic representative images of AW8507 cells post different treatments; (b) Ass...
MTT of 3-day treatment of the 100 nM gefitinib alone or in combination with 100 nM or 1 μM gemcitabi...
<p>(<b>A</b>) Example images obtained with IN Cell 1000 showing SKBR3 cells treated for 72 h with 10...
<p><b>A</b>. (a) Cell viability analysis according to treatment with simvastatin (10 μM) and <i>NF-κ...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
<p><i>(A and B)</i> MTT cell viability assays to evaluate the potential of metformin (0–20 mM) or lo...
<p>The concentration-response response for each drug was used to determine the concentration that in...
<p>Three relatively resistant cell lines to gefitinib (UM-UC3, UM-UC13, and KU-7) and one sensitive ...
<p>Cells were treated with three different sequences of gefitinib and docetaxel (D→G; G→D; D+G). The...
<p>The effects of (A) gefitinib and (B) erlotinib (1–10 μM) on cell proliferation of A549 cells were...
<p>(A) MTS assay comparing the survival curves of control JLO-1 to 2 µM gefitinib-treated JLO-1 when...
<p>The cells were treated with YC alone or in combination with gefitinib or rapamycin for 48 h. The ...
<p>Bladder tumor growth of combination treatment arm compared to control arm (P<0.02). Ten mice per ...
<p>(A) PC-9/wt, PC-9/gefB4 and PC-9/gefE3 cells were treated with gefitinib (nM) at various concentr...
<p>(<b>A</b>) SKBR3 and MDA-MB-468 cells were treated with DIM (15 µM) and Herceptin (0.75 µg/ml), e...
<p>(a) Confocal microscopic representative images of AW8507 cells post different treatments; (b) Ass...
MTT of 3-day treatment of the 100 nM gefitinib alone or in combination with 100 nM or 1 μM gemcitabi...
<p>(<b>A</b>) Example images obtained with IN Cell 1000 showing SKBR3 cells treated for 72 h with 10...
<p><b>A</b>. (a) Cell viability analysis according to treatment with simvastatin (10 μM) and <i>NF-κ...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
<p><i>(A and B)</i> MTT cell viability assays to evaluate the potential of metformin (0–20 mM) or lo...
DOI
Add to ORKG